Back to search results

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

Abroad (travel likely)Recruiting

Conditions

Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • BCCA - Vancouver, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Alina Gerrie) · 604 877-6000

  • CancerCare Manitoba, Winnipeg, Manitoba, Canada

    Contact: Study coordinator (Versha Banerji) · 204 787-4904

  • Regional Health Authority B, Zone 2, Saint John, New Brunswick, Canada

    Contact: Study coordinator (Alfonso Rivera Duarte) · 506 648-7109

  • Lakeridge Health Oshawa, Oshawa, Ontario, Canada

    Contact: Study coordinator (Lakshman Vasanthamohan) · 905 576-8711

  • Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

    Contact: Study coordinator (David A. MacDonald)

  • The Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Tanya Skamene) · 514 340-8222
Study leads

  • Matthew Cheung

    Study Chair

    Odette Cancer Centre, Sunnybrook Helath Sciences Centre, Toronto, Ontario, Canada

View source on ClinicalTrials.gov(opens in a new tab)